Allogeneic Bone Marrow Transplantation for Patients with Acute Lymphoblastic Leukemia or Acute Non- Lymphoblastic Leukemia (After Remission Induction Failure, in Relapse or in Second or Subsequent Remission) and Patients with Chronic Myelogenous Leukemia (in Accelerated or Blastic Phase)

Closed

Phase

Accrual

98%

Published

Abbreviated Title

Allogeneic Bone Marrow Transplantation for Patients with Acute Lymphoblastic Leukemia or Acute Non- Lymphoblastic Leukemia (After Remission Induction Failure, in Relapse or in Second or Subsequent…

Activated

12/30/1986

Closed

10/01/1991

Publication Information Expand/Collapse

2018

Value of Anti-Cancer Drugs in SWOG Phase III Clinical Trials: Evidence from Multiple Evaluation Mechanisms

V Nghiem;R Vaidya;M Banegas;D Hershman;J Unger AcademyHealth Annual Research Meeting (June 23-26, 2018, Seattle, WA), poster #B-335

1995

Cytogenetic correlation with disease status and treatment outcome in advanced stage leukemia post bone marrow transplantation: A Southwest Oncology Group study (SWOG-8612).

ML Slovak;KJ Kopecky;SR Wolman;JP Henslee-Downey;FR Appelbaum;SJ Forman;KG Blume Leukemia Research 19(6):381-388

1993

A prospective randomized comparison of total body irradiation-etoposide versus busulfan-cyclophosphamide as preparatory regimens for bone marrow transplantation in patients with recurrent leukemia who were not in first remission: A Southwest Onology Group study.

KG Blume;KJ Kopecky;JP Henslee-Downey;SJ Forman;PJ Stiff;CF LeMaistre;FR Appelbaum Blood 81(8):2187-2193

Cytogenetic correlation with disease status and treatment outcome in poor prognosis leukemia post bone marrow transplantation: A Southwest Oncology Group study (SWOG-8612).

ML Slovak;KJ Kopecky;SR Wolman;JP Henslee-Downey;SJ Forman;KG Blume Blood 82(10)(Suppl.1)(#1150)